ArticleFrontiers in psychiatry2026
Neuroimmune-driven abrupt neuropsychiatric symptoms in children: preventing pathological fear consolidation.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is defined by an abrupt onset of neuropsychiatric symptoms, traditionally viewed through the lens of obsessive-compulsive behaviors. However, it is also characterized by a state of extreme fear. While medical management addresses the biological triggers, this period creates a high-stakes emergency in human fear-learning that remains unaddressed by standard protocols. The current gold standard, exposure and response prevention (ERP), is theoretically mismatched to this unconditioned fear state. How do we help children endure and learn from pre-reflexive fear that is not cognitively mediated, not titratable, involuntary, and remains at peak without habituation? While we wait for the child to become "stable enough" for therapy, primitive learning is already occurring. The question is whether that learning is therapeutically guided or left to raw survival. This conceptual paper proposes Fear Rebalance Therapy (FRT), a theoretical framework requiring empirical validation. It is a developmentally unfolding framework that integrates co-regulation, survival learning and inhibitory learning principles. FRT guides the child to learn the safety of the external world even while the body signals imminent threat. Many of the initial symptoms may be reconceptualized as a threat-dominant physiological state, leading to a cascade of defensive reactions. The PANS index episode represents a critical branch point. Without guided learning, incidental conditioning can lead to chronic, sensitized disability. FRT aims to help children learn to regulate their emotional responses to these internal alarms. This framework proposes that while neuroimmune responses trigger the crisis, the nature of the learning during that crisis may determine trajectory. Early psychological intervention should be an active component of crisis management rather than a post-crisis adjunct to medical care. Importantly, FRT addresses psychological learning processes occurring during the acute episode, not the underlying neuroimmune mechanisms, which remains the domain of medical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.